# Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism

> **NCT07466381** · PHASE2,PHASE3 · COMPLETED · sponsor: **dr. Siti Nurlaela, SpN** · enrollment: 35 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** oxyhydrogen nanobubble infusion

## Key facts

- **NCT ID:** NCT07466381
- **Lead sponsor:** dr. Siti Nurlaela, SpN
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-01-31
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07466381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07466381, "Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07466381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*